- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Thomas H. Hawk III (Tom)
News 15 results
Recognition
December 1, 2023
M&A Advisor Honors King & Spalding With Healthcare/Life Sciences Deal of the Year Award
In the News · Source: McKnight’s Senior Living
June 21, 2023
Tom Hawk explains why there has been a recent spike of activity in healthcare transactions
Recognition
June 1, 2023
Chambers USA 2023 Recognizes 186 K&S Lawyers and 84 K&S Practice Groups as Leaders in Their Fields
In the News · Source: Modern Healthcare
January 2, 2023
Tom Hawk explains why health systems will likely face continued financial struggles, driven by ongoing staffing issues
Events 16 results
Speaking Engagement
September 21, 2023
Tom Hawk to Speak at Health Connect South’s Annual Conference
Speaking Engagement
June 27, 2023
Tom Hawk to Speak at the American Health Law Association’s Annual Meeting
Webinar
June 20, 2023
New Developments in Regulatory Review Requirements for Healthcare M&A Transactions
Conference
March 20, 2023
32nd Annual King & Spalding Health Law & Policy Forum
Insights 2 results
Client Alert
October 4, 2021
Study Shows Hospital M&A Deals Linked to Improved Quality of Care
Newsletter
October 4, 2021
Health Headlines – October 4, 2021